Evaluation of 3D printed PCL/PLGA/beta-TCP versus collagen membranes for guided bone regeneration in a beagle implant model by Won, JY et al.
Biomedical Materials
PAPER • OPEN ACCESS
Evaluation of 3D printed PCL/PLGA/β-TCP versus
collagen membranes for guided bone regeneration
in a beagle implant model
To cite this article: J-Y Won et al 2016 Biomed. Mater. 11 055013
 
View the article online for updates and enhancements.
Related content
Porosity effect of 3D-printed
polycaprolactone membranes on calvarial
defect model for guided bone regeneration
Jin-Hyung Shim, Jae-hyang Jeong, Joo-
Yun Won et al.
-
Efficacy of rhBMP-2 loaded PCL/PLGA/-
TCP guided bone regeneration membrane
fabricated by 3D printing technology for
reconstruction of calvaria defects in rabbit
Jin-Hyung Shim, Min-Chul Yoon, Chang-
Mo Jeong et al.
-
Effects of different rhBMP-2 release
profiles in defect areas around dental
implants on bone regeneration
Jae Ho Jo, Sung Wook Choi, Jae Won
Choi et al.
-
Recent citations
Comparing Properties of Variable Pore-
Sized 3D-Printed PLA Membrane with
Conventional PLA Membrane for Guided
Bone/Tissue Regeneration
Hao Yang Zhang et al
-
Histological, Histomorphometric, and
Osteogenesis Comparative Study of a
Novel Fabricated Nanocomposite
Membrane versus a Cytoplast Membrane
Abbas Haghighat et al
-
Enhancement in sustained release of
antimicrobial peptide and BMP-2 from
degradable three dimensional-printed
PLGA scaffold for bone regeneration
Lei Chen et al
-
This content was downloaded from IP address 141.223.153.36 on 21/06/2019 at 03:33
© 2016 IOP Publishing Ltd
1. Introduction
Adequate bone volume is critical for the successful 
outcome of dental implants and prosthetic 
superstructures and to ensure satisfactory predictable 
aesthetics and long-term prognoses [1, 2]. To enhance 
the bone volume in the jaw, various methods such 
as distraction osteogenesis [3], osteoinduction [4], 
osteoconduction [5], and guided bone regeneration 
(GBR) [6, 7] have been introduced. Among these 
methods, GBR, a surgical procedure that uses a barrier 
membrane with or without grafting materials, has 
been recognized as the method that yields the most 
predictable results for new bone regeneration in peri-
implant bone defect sites [8, 9].
During the GBR procedure, the bone defect is 
separated from the surrounding connective tissues to 
prepare a space for new bone formation. The barrier 
membrane plays important roles during this proce-
dure [9, 10] and is required to exhibit properties such as 
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Abstract
Here, we compared 3D-printed polycaprolactone/poly(lactic-co-glycolic acid)/β-tricalcium 
phosphate (PCL/PLGA/β-TCP) membranes with the widely used collagen membranes for guided 
bone regeneration (GBR) in beagle implant models. For mechanical property comparison in dry 
and wet conditions and cytocompatibility determination, we analyzed the rate and pattern of cell 
proliferation of seeded fibroblasts and preosteoblasts using the cell counting kit-8 assay and scanning 
electron microscopy. Osteogenic differentiation was verified using alizarin red S staining. At 8 weeks 
following implantation in vivo using beagle dogs, computed tomography and histological analyses 
were performed after sacrifice. Cell proliferation rates in vitro indicated that early cell attachment 
was higher in collagen than in PCL/PLGA/β-TCP membranes; however, the difference subsided by 
day 7. Similar outcomes were found for osteogenic differentiation, with approximately 2.5 times 
greater staining in collagen than PCL/PLGA/β-TCP, but without significant difference by day 14. 
In vivo, bone regeneration in the defect area, represented by new bone formation and bone-to-
implant contact, paralleled those associated with collagen membranes. However, tensile testing 
revealed that whereas the PCL/PLGA/β-TCP membrane mechanical properties were conserved in 
both wet and dry states, the tensile property of collagen was reduced by 99% under wet conditions. 
Our results demonstrate in vitro and in vivo that PCL/PLGA/β-TCP membranes have similar levels 
of biocompatibility and bone regeneration as collagen membranes. In particular, considering that 
GBR is always applied to a wet environment (e.g. blood, saliva), we demonstrated that PCL/PLGA/β-
TCP membranes maintained their form more reliably than collagen membranes in a wet setting, 
confirming their appropriateness as a GBR membrane.
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biocompatibility, cell occlusivity, tissue integration, 
space maintenance, and manageability [11]. To date, 
both non-resorbable and resorbable commercially 
available membranes with unique properties have 
been used in the clinic because they have met consumer 
needs as GBR membranes [12, 13]. Most recently, 
resorbable membranes have been preferentially utilized 
because the non-resorbable forms inevitably require a 
surgical procedure for membrane removal, which can 
cause further patient discomfort, risk of tissue dam-
age, and additional costs and duration of treatments 
[13, 14]. Moreover, non-resorbable membranes carry 
limitations such as a high membrane exposure rate 
and infection problems; thus, it is primarily used for 
specific indications in the form of titanium-reinforced 
expanded-polytetrafluoroethylene (e-PTFE) or as a 
titanium-mesh [1, 15].
In comparison, the collagen membrane, which 
is widely used as a representative resorbable GBR 
membrane, is mechanically malleable and adaptable, 
exhibiting excellent manipulability [16, 17]. Owing 
to its collagen property, it has advantages such as a 
hemostatic function, early wound stabilization, and 
semipermeablity [18], but it also has drawbacks such 
as unfavorable mechanical properties [19] and inad-
equate barrier stability over time [20–22]. Accordingly, 
studies on synthetic bioresorbable materials have been 
conducted for the fabrication of form-stable resorba-
ble GBR membranes with a sufficient degradation rate 
[13, 23]. Bioresorbable materials such as polyglycolides 
(PGAs), polylactides (PLAs), and copolymers have been 
used for medical purposes [24]. The synthetic mem-
branes prepared using those materials have been shown 
to be sufficiently biocompatible and biodegradable to 
also be used as barrier membranes [25–29].
Bioresorbable synthetic polymers are often used 
in tissue-engineering scaffolds that can be prepared 
through foaming/particulate leaching, phase separa-
tion, freeze-drying, and electrospinning [30]. How-
ever, these conventional fabrication techniques utilize 
toxic solvents that adversely affect cells and tissues if 
not completely removed. Furthermore, it is difficult to 
adjust the thickness, pore size, or external shape of the 
fabricated scaffold, and to maintain the architectural 
consistency [30, 31].
In contrast, three dimensional (3D) structures can 
be prepared without the aforementioned difficulties 
using the 3D printing method, which is based on comp-
uter-aided design/computer-aided manufacturing 
(CAD/CAM) and layer-by-layer processes [32, 33]. In 
particular, the multi-head deposition system (MHDS), 
an advanced type of extrusion-based 3D printing 
technology, has four dispensing heads for preparing 
hybrid scaffolds containing multiple biomaterials, 
and can prepare 3D microstructures precisely within 
a short time [34, 35]. For example, Shim et al [31] fab-
ricated thin-membrane-type scaffolds using MHDS 
by blending polycaprolactone (PCL), poly(lactic- 
co-glycolic acid) (PLGA), and beta-tricalcium 
 phosphate (β-TCP), and confirmed that the PCL/
PLGA/β-TCP membrane prepared using the 3D print-
ing technology promoted appropriate bone-formation 
in a rabbit calvaria bone-defect model [36–38]. This 
bioresorbable PCL/PLGA/β-TCP membrane has the 
biological and mechanical advantages of both PCL and 
PLGA, as well as the osteoconductivity of TCP. In addi-
tion, it can be prepared with diverse thicknesses and 
pore sizes via the 3D printing technology, and can be 
effectively used as a GBR membrane for peri-implant 
bone defects [39]. In a further Shim et al study [40], 
GBR procedures were conducted at the buccal open 
defects surrounding implants in the mandible of beagle 
dogs in designed clinical situations, and the bone gener-
ation effects of the PCL/PLGA/β-TCP membrane were 
compared with those of the non-resorbable titanium 
membrane. The results of this study confirmed that the 
PCL/PLGA/β-TCP membrane promoted sufficient 
new bone formation to serve as a GBR membrane [40].
In the current study, the bone regeneration ability of 
the 3D-printed PCL/PLGA/β-TCP membrane was evalu-
ated and compared with that of the collagen membrane, a 
widely used resorbable membrane, during the GBR proce-
dure for peri-implant bone defects in the beagle mandible.
2. Experimental section
2.1. PCL/PLGA/β-TCP membrane generation 
using 3D printing technology
2.1.1. Preparation of blended PCL/PLGA/β-TCP 
Collagen membrane (GENOSS, Suwon, Korea) and 
PCL/PLGA/β-TCP membrane were used as barrier 
membranes. The PCL/PLGA/β-TCP membrane was 
prepared using the thermal melting process by mixing 
PCL (19561-500G, 43 000–50 000 Mw; Polysciences 
Inc., Warrington, PA, USA), PLGA (430471-5G, 50 000–
75 000 Mw; Sigma-Aldrich, St. Louis, MO, USA), and 
β-TCP (average diameter: 100 nm, Berkeley Advanced 
Biomaterials Inc., Berkeley, CA, USA). Briefly, PCL 
(0.4 g) and PLGA (0.5 g) granules were melted and 
mixed in a glass container for 10 min at 130 °C, and 
powder-type β-TCP (0.1 g) was added to the dissolved 
PCL and PLGA mixture, which was further mixed 
for five min. Then the PCL/PLGA/β-TCP mixture 
was put into the 10 ml steel syringe of the multi-head 
deposition system (MHDS) and maintained at 135 °C 
for dispensing.
2.1.2. Fabrication of PCL/PLGA/β-TCP membranes 
The MHDS, an extrusion-based 3D printing system 
used to prepare the PCL/PLGA/β-TCP membrane, 
was composed of four heads that could control the 
temperature, pneumatic pressure, and motion during 
extrusion. The system could simultaneously prepare 
four membranes [31]. Blended PCL/PLGA/β-TCP 
fibers were dispensed from the steel nozzle of the head at 
135 °C and 650 kPa. In total, three layers were stacked to 
fabricate PCL/PLGA/β-TCP membranes using the layer-
by-layer process. The PCL/PLGA/β-TCP membrane 
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had a 3D-multilayer mesh-type structure similar to that 
of the resorbable collagen membrane. The 3D-printed 
membranes included a triangular pore structure. The 
overall dimensions were 30 mm  ×  20 mm  ×  0.25 mm 
(figure 1). The width of the strut was 300 µm and the 
pore size was 200 µm. Therefore, the calculated porosity 
was approximately 40%.
2.1.3. Mechanical testing of collagen and PCL/
PLGA/β-TCP membranes 
A membrane-type specimen for a mechanical tensile 
test was fabricated using the 3D printing system. The 
experiment condition was based on ISO527 (Tensile 
test on plastics) and the dimensions of the specimen 
were determined according to Specimen Type 4 of 
ISO527-3. The tensile test of the membranes was 
performed using a single-column tensile test machine 
(Model 3345, Instron Co., Norwood, MA, USA) under 
dry and wet (soaking the membranes in a medium for 
18 h) membrane conditions. The overall dimensions 
of the collagen and PCL/PLGA/β-TCP membranes 
were 30 mm  ×  10 mm  ×  0.3 mm. For the PCL/PLGA/ 
β-TCP membrane, the printed strut size was 300 µm, 
and the membrane pore size was 200 µm. The load and 
displacement were monitored at a constant cross-head 
speed of 5 mm min−1.
2.2. In vitro analyses
2.2.1. Cell culture and proliferation assay 
Mouse fibroblasts (NIH3T3, ATCC #CRL-1658) and 
preosteoblasts (MC3T3-E1, ATCC #CRL-2593) were 
maintained in Dulbecco modified Eagle’s medium 
(DMEM) and α-MEM containing 10% fetal bovine 
serum (FBS) and 1% penicillin and streptomycin 
(all from Invitrogen, Carlsbad, CA, USA). For 
cell seeding on the membranes, all membranes 
(10 mm  ×  10 mm  ×  0.3 mm) were pre-wetted in 
culture medium for 2 h and then irradiated under UV 
for 30 min. Subsequently, 3  ×  105 cells were seeded on 
each membrane and the rates of proliferation on the 
membrane were analyzed via a Cell Counting Kit-8 
(CCK-8, Dojindo, Rockville, MD, USA) on day 2, 4, 
and 7.
2.2.2. Osteogenic differentiation and Alizarin red 
staining 
The MC3T3-E1-seeded membranes were incubated in 
culture medium for 3 d, which was then replaced with 
osteogenic medium composed of α-MEM plus 20% 
FBS, 10-8 M dexamethasone, 0.2 mM ascorbic acid, 
10 mM β-glycerol phosphate (all from Sigma-Aldrich) 
and 1% penicillin/streptomycin. The membranes were 
fixed with 4% paraformaldehyde on day 7 and 14, then 
stained with alizarin red to measure calcium deposition. 
For the quantification of staining, membranes were 
soaked in 10% cetylpyridinium chloride for 10 min 
at room temperature and the optical density was 
measured at 570 nm using a microplate reader (Epoch, 
BioTek, Winooski, VT, USA).
2.2.3. Scanning electron microscopy (SEM) 
To assess the morphology of the membrane surface 
alone or following cell seeding, we performed 
SEM a using high resolution SEM (HR-SEM) with 
acceleration voltage of 10 kV (FEI, Nova NanoSEM 
450) as previously described [40].
2.3. In vivo analyses
2.3.1. Experimental animals 
Three systemically healthy male beagle dogs aged 18 
months and weighing approximately 10 kg were used 
in this study. All the experimental animals were fed a 
soft food diet to preserve their dentition with a healthy 
periodontium. The animal selection and management 
as well as the surgical procedures were approved by 
the Ethics Committee on Animal Experimentation 
of Chonnam National University (CNU IACUC-
TB-2013-10). All the experiments were performed 
at the animal dental laboratory accredited by the 
Chonnam National University Animal Hospital.
2.3.2. Experiment design 
A total of 12 implants (INNO Implant, Cowelmedi, 
Busan, Korea), 3.0 mm in diameter and 6.0 mm in 
length, were bilaterally placed in healed extraction 
sites (below). A total of four peri-implant dehiscence 
defects were observed per animal, and the following two 
therapeutic methods were randomly applied:
Figure 1. Photographs of the PCL/PLGA/β-TCP membrane.
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• Collagen group: Collagen Membrane (GENOSS, 
Suwon, Korea) with a deproteinized bovine bone 
grafting material (Bio-Oss, Geistlich Biomaterials, 
Wolhusen, Switzerland).
• PCL/PLGA/β-TCP group: PCL/PLGA/β-TCP 
membrane with a deproteinized bovine bone 
grafting material (Bio-Oss).
2.3.3. Surgical procedures 
The first surgery was performed to extract the second 
and fourth premolars (P2 and P4) under general 
anesthesia induced by intravenous injection of atropine 
(0.05 mg kg−1 IV; Dai Han Pharm Co., Seoul, Korea) 
and intramuscular injection of a combination of 
xylazine (Rompun, Bayer Korea Co., Seoul, Korea), 
followed by inhalation of anesthesia with isoflurane 
(Choongwae Co., Seoul, Korea). At the surgical sites, 
dental infiltration anesthesia was used with 1 ml 2% 
lidocaine HCL and 1:100 000 epinephrine (Yu-Han 
Co., Gunpo, Korea). The targeted premolars were 
bilaterally extracted. The extraction site was sutured 
with 4-0 nylon (Mersilk, Ethicon Co., Livingston, UK) 
for healing. Oral prophylaxis was performed on the 
remaining teeth. The stitches were removed after 10 d, 
and the extraction sites were allowed to heal.
The second surgery was performed after the 8 weeks 
recovery period. General anesthesia and local infiltra-
tion anesthesia were performed as in the first surgery. A 
horizontal incision was made on the experimental site, 
and vertical incisions were made through the mucog-
ingival junction that extended into the alveolar mucosa 
at the mesial and distal ends of each defect. The muco-
periosteal flaps were elevated to expose the edentulous 
alveolar ridge. Two identical dehiscence defects (4 mm 
apicocoronally and 2 mm mesiodistally) were surgically 
prepared on the buccal sides of the left and right partial 
edentulous ridges (figure 2). In each of the four defects, 
an implant was placed following serial drilling accord-
ing to the standard protocol. The platform of the fixture 
was located at the level of the alveolar crest.
Next, 0.1 mg deproteinized bovine bone graft-
ing material (Bio-Oss) was quantified and dampened 
in sterile saline for 5 min, then positioned at the buc-
cal defect. Upon completion of the grafting, collagen 
membranes (Collagen Membrane, GENOSS) or PCL/
PLGA/β-TCP membranes were randomly positioned 
at the buccal defect (figure 3). All membranes were cut 
to a size that covered 2–3 mm of the adjacent alveolar 
bone to overlap the entire defect. To enhance the sta-
bility of the grafting material, titanium pins (Dentium 
Co., Seoul, Korea) were used for the fixation. To obtain 
primary wound closure, the buccal flaps were carefully 
released and sutured. All surgeries were performed by 
the same professionally trained operator.
2.3.4. Post-operative care and sacrifice 
Antibiotics such as penicillin G procaine and penicillin 
G benzathine were intramuscularly injected (1 ml/5 kg) 
immediately and 48 h after the surgery. Plaque was 
controlled using 2% chlorhexidine gluconate through 
daily flushing of the oral cavity until the end of the 
study. The animals were kept on a soft diet for 2 weeks, 
followed by a regular diet. Animals were sacrificed 8 
weeks post-operatively through intravenous injection 
of concentrated sodium pentobarbital (Euthasol, 
Delmarva Laboratories Inc., Midlothian, VA, USA). 
The mandibles of the sacrificed beagles were harvested 
after cutting them to include the alveolar bones near the 
implant, as well as the membranes and surrounding 
mucosae. The 12 harvested mandible block sections were 
fixed using neutral buffered formalin (Sigma Aldrich).
2.3.5. Micro-computed tomography (µCT) analysis 
After fixation, 3D µCT images were generated to 
analyze the new bone density and new bone volume of 
the peri-implant dehiscence defect area. The specimens 
were wrapped with Parafilm M® (Bemis Company, Inc., 
Neenah, Wisconsin, USA) to keep them from drying 
during the scanning process. Then, all the samples were 
scanned with 130 kV energy, 60 µA intensity, and a 
Figure 2. Schematic diagram of the peri-implant defect model. The implant (3.0 mm  ×  6.0 mm) was inserted in a standardized 
defect, 4 mm in height and 2 mm in width.
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7.10 µm-pixel resolution using a bromine filter 
(0.25 mm) (Skyscan-1173, version 1.6, Bruker-CT, 
Kontich, Belgium). Reconstruction was performed 
using Nrecon software (version 1.6.10.1, Bruker-CT). 
All the applied scan and reconstruction parameters were 
identical for all the specimens. The overall augmented 
contour was evaluated at the 3D reconstructed view. 
Boundaries were set as follows to standardize the region 
of the augmented volume to be analyzed:
• Any augmented volume directly superior or lingual 
to the implant in its axial plane was excluded.
• Any augmented volume inferior to the buccal 
extension of the inferior border of the defect was 
excluded.
The region of interest (ROI) was 1 mm in width and 
2.5 mm in height from the implant platform (figures 4 
and 5).
Figure 3. Surgical operation procedures. (a) The alveolar ridge was trimmed for implant insertion. (b) Buccal defects were created 
and implants were inserted into the partial edentulous mandibular alveolar ridge. (c) All the peri-implant defects were filled with the 
grafting material. Then, all the membranes were placed randomly on the defect.
Figure 4. The region of interest; 1 mm in width and 2.5 mm in height from the implant platform. (a) Cross-sectional view  
(b) occlusal view.
Figure 5. 3D images obtained via micro-computed tomography. (a) 3D image of the mandible block section. (b) 3D image without 
the old bone. (c) 3D image of the region of interest.
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The following parameters were calculated within 
the ROI:
• Total augmented volume (TAV; mm3)
: Area occupied by the total augmented volume 
within the ROI
• New bone volume (NBV; mm3)
:  Area occupied by the new bone volume within  
the ROI
• Remaining bone substitute volume (RBV; mm3)
: Area occupied by the remaining bone substitute 
volume within the ROI
• Non-mineralized tissue volume (NMV; mm3)
: Area occupied by the non-mineralized tissue 
volume within the ROI
2.3.6. Histomorphometric analysis 
Upon completion of the µCT analysis, the specimens 
were cleansed and dehydrated using an ethanol series 
with increasing concentration. After the dehydration 
was completed, infiltration was conducted using a 
mixture of ethanol and Technovit 7200 resin (Heraeus 
Kulzer, Hanau, Germany) while increasing the resin 
ratio. Then the specimen was fixed on an embedding 
frame to perform embedding using a UV embedding 
system (Exakt 520, Kulzer) to cure the resin for 1 d. 
The polymerized specimen block was longitudinally 
sectioned at each implant center using the Exakt 
diamond cutting system (Kulzer Exakt 300 CP), and 
attached to slides using an adhesive press system. The 
final slides were ground to have a thickness ranging 
from the initial 400 µm to the final 40  ±  5 µm using 
the Exakt grinding system (Kulzer Exakt 400CS). To 
observe the newly regenerated bone in the specimen, 
Goldner Trichrome staining was conducted before 
mounting the sample, then final slides were prepared. 
The final slide images were captured using a CCD 
camera (Spot Insight 2 Mp scientific CCD digital 
camera system, Diagnostic Instruments, Inc., Sterling 
Heights, MI, USA) with an adaptor (U-CMA3, 
Olympus, Tokyo, Japan) mounted onto a light 
microscope coupled to a computer (BX51, Olympus). 
For the analysis of the captured images, i-Solution ver. 
8.1 (IMT i-Solution, Inc., Coquitlam, BC, Canada) 
was used. The general specimen images were observed 
at  ×12.5 magnification; for the histometric analyses, 
×40 magnification was used. For the histometric 
analysis, a single, professionally trained and blinded 
investigator measured the following items.
The area of interest (AOI) was 1 mm width and 
height from the implant platform to the old bone (OB) 
(figure 6).
The following measurements were analyzed and 
recorded within the AOI.
• New bone area (NBA; %)
: Area occupied by the new bone/AOI  ×  100 (%)
Figure 6. Parameters measured in the histologic specimens. Red box  =  area of interest. Blue arrow  =  platform of the implant. 
Yellow arrow  =  most coronal point of the new bone. White arrow  =  most coronal point of the osseointegration site. Green 
arrow  =  most coronal point of the old bone.
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• Remaining bone substitute area (RBA; %)
: Area occupied by the remaining bone substitute/
AOI  ×  100 (%)
• Bone-to-implant contact (BIC; %)
: Length of the contact with the new bone/total 
length of the exposed threads  ×  100 (%)
• Bone crest (BC)-OB (%)
: Distance from the BC to the OB/distance from the 
implant platform to the OB  ×  100 (%)
• Coronal point of osseointegration (CO)-OB (%)
: Distance from the most CO to the OB/distance 
from the implant platform to the OB  ×  100 (%)
2.3.7. Statistical analysis 
All the experimental data were expressed as the means, 
standard deviations, and medians. All the statistical 
analyses were conducted using software R (version 
3.1.3). The treatment group (Collagen group and 
PCL/PLGA/β-TCP group) was set as an independent 
factor, and the dog number was set as a random factor. 
To compare the radiographic and histomorphmetric 
parameters of the groups, a non-parametric mixed 
model was used [41]. The statistical significance level 
was 5% and post hoc analyses were performed.
3. Results
3.1. SEM analysis of the PCL/PLGA/β-TCP 
membrane
Representative SEM images of the collagen and PCL/
PLGA/β-TCP membranes are shown in figure 7. The 
surface of the collagen membrane was smooth and 
dense (figures 7(a)–(c)), whereas the PCL/PLGA/ 
β-TCP surface was rough owing to the β-TCP particles. 
In particular, the PCL/PLGA/β-TCP membrane 
showed a triangular and uniform pore architecture that 
was fully interconnected (figures 7(d)–(f)).
3.2. Mechanical testing of collagen and PCL/
PLGA/β-TCP membranes
To compare the mechanical properties of the PCL/
PLGA/β-TCP membrane with those of the collagen 
membrane, a tensile test was performed under dry and 
wet conditions. The tensile test results of the collagen 
(a) (b) (c)
(d) (e) (f)
Figure 7. SEM images of collagen ((a)–(c)) and PCL/PLGA/β-TCP ((d)–(f)) membranes. Magnification, ×75 in ((a) and (d)), 
×200 in ((b) and (e)) and  ×1000 in ((c) and (f)). The collagen membrane showed a smooth surface without visible pore-like fabric, 
while the PCL/PLGA/β-TCP had a rough surface and a fully interconnected porous architecture.
Table 1. Maximum tensile load and elastic modulus of collagen and PCL/PLGA/β-TCP 
membranes under dry and wet condition (means  ±  SDs; n  =  3).
Group
Maximum tensile load (N) Elastic modulus (MPa)
Dry Wet Dry Wet
Collagen 68.8  ±  15.3 12.8  ±  1.4 874.9  ±  87.3 7.9  ±  0.1
PCL/PLGA/β-TCP 15.7  ±  0.9 10.3  ±  0.9 803.0  ±  17.8 594.7  ±  66.7
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and PCL/PLGA/β-TCP membranes are shown in 
figures 8 and 9, and table 1. From the load-displacement 
curve (figure 8), the maximum load of the collagen 
membrane in the dry condition was approximately 
4-times higher than that of the PCL/PLGA/β-TCP 
membrane. In contrast, in the wet condition, the 
maximum load of collagen (12.8 N) was 24.3% higher 
than that of PCL/PLGA/β-TCP membrane (10.3 N). 
On the other hand, as shown in figure 9, a considerable 
decrease of the elastic modulus (the slope of first linear 
portion of the stress–strain curve reflecting membrane 
rigidity) between the dry (874.9  ±  87.3 MPa) and 
wet (7.9  ±  0.1 MPa) conditions was measured in the 
collagen membrane (P  <  0.001). Specifically, the elastic 
modulus of the collagen membrane in the dry condition 
fell by 99.1%. In contrast, that of the PCL/PLGA/ 
β-TCP membrane in the dry condition decreased by 
26% when the membrane was wetted (P  <  0.01). Thus, 
the decreasing rate of the elastic modulus of the PCL/
PLGA/β-TCP membrane in the wet condition was 
much less severe than that of the collagen membrane.
3.3. In vitro results
To evaluate the cytocompatibility of the membrane, 
we first observed the morphology and proliferation of 
fibroblasts (NIH3T3) and preosteoblasts (MC3T3-E1 
cells) seeded onto the membranes. On day 2, the 
number of attached cells on the collagen membrane 
was approximately 2.6-times higher than that on 
PCL/PLGA/β-TCP for both cell types. However, 
proliferation of the MC3T3-E1 cells on PCL/PLGA/ 
β-TCP increased and had reached similar levels as 
that on the collagen membrane by day 4 (P  >  0.05). 
In parallel, SEM images showed that the MC3T3 cells 
completely covered the surface of the collagen and 
PCL/PLGA/β-TCP membranes on day 7 (figure 
10(b)). On the other hand, the optical density of 
NIH3T3 cells did not differ between membrane 
type (P  >  0.05) at day 7 even though it had retained 
a significant difference up to 4 d (P  <  0.001) (figure 
10(a)). These results suggested that the PCL/PLGA/ 
β-TCP membrane provide an appropriate 
environment for cell proliferation.
Figure 8. Tensile testing results (load-displacement curve) of collagen and PCL/PLGA/β-TCP membranes in the dry and wet 
conditions.
Figure 9. Elastic modulus of collagen and PCL/PLGA/β-TCP membranes in the dry and wet conditions (*P  <  0.001, **P  <  0.01). A 
substantial decrease of elastic modulus between dry and wet conditions was seen for the collagen membrane.
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We further investigated the osteogenic differentiation 
of MC3T3-E1 cells on collagen and PCL/PLGA/β-TCP 
membranes. The MC3T3-E1-seeded membranes were 
placed in osteogenic media for 7 and 14 d and then fixed 
with 4% paraformaldehyde. Osteogenic differentiation of 
the MC3T3-E1 cells on the membranes was assessed by 
alizarin red S staining, which revealed increased calcium 
deposition on the membranes (figure 11(a)). To quantify 
the staining, stained dyes were extracted from the mem-
branes using 10% cetylpyridinium chloride in 10 mM 
sodium phosphate. On day 7, the level of osteogenic dif-
ferentiation of MC3T3-E1 cells on the PCL/PLGA/β-TCP 
membrane was less than that on the collagen membrane. 
However, no significant difference between membrane 
type could be determined on day 14. The quantitative 
analysis results were consistent with the staining results 
(figure 11(b)). Taken together, the in vitro experiments 
demonstrated that the PCL/PLGA/β-TCP membrane 
exhibited similar efficacy as a GBR membrane with respect 
to cytocompatibility and osteogenic differentiation as 
compared to collagen.
3.4. In vivo results
3.4.1. Clinical findings 
All experimental animals survived the surgical 
procedures, and the 12 implant sites healed without 
noted problems. No implant failure or dropout was 
observed, and no membrane exposure or separation 
occurred during the healing period. No complication 
was reported from either experimental group during the 
study period.
3.4.2. Volumetric analysis using µCT 
In the collagen group, some specimens were observed 
wherein the grafting materials were scattered in the 
peri-implant dehiscence defect area. In comparison, 
in the PCL/PLGA/β-TCP group, the grafting materials 
formed a shape in the peri-implant dehiscence defect 
area in most specimens (figure 12).
The volumetric measurements are summarized in 
table 2 and figure 13. The PCL/PLGA/β-TCP group 
showed higher levels of new bone volume (mm3) 
and remaining bone substitute volume (mm3) than 
the collagen group, but the differences were statisti-
cally insignificant (NBV (mm3), P  =  0.339; and RBV 
(mm3), P  =  0.295). Conversely, the collagen group 
showed higher levels of total augmented volume 
(mm3) and non-mineralized tissue volume (mm3) 
than the PCL/PLGA/β-TCP group, but the differ-
ences were also statistically insignificant (TAV (mm3). 
P  =  0.127; and NMV (mm3), P  =  0.185).
3.4.3. Histologic findings 
In the collagen group (figure 14), a small amount of 
new bone was formed in the implant in the buccal peri-
implant dehiscence defect area. In some specimens, the 
membrane was not observed because it was absorbed. In 
the specimen whose membrane was completely absorbed, 
Figure 10. The cell morphology and proliferation assays of NIH3T3 (a) and MC3T3-E1 (b) cells on the collagen and PCL/PLGA/ 
β-TCP membranes showed that the attached cells grew well. (***P  <  0.001, NS  =  no significant difference).
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Figure 12. Micro-computed tomography images of the collagen and PCL/PLGA/β-TCP groups.
Figure 11. Alizarine red S staining (a) and quantification (b) indicated that no difference was observed in osteogenic differentiation 
between collagen and PCL/PLGA/β-TCP membranes at day 14.
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fibrous tissues were observed around the implant, and the 
grafting materials were observed only because they were 
scattered in the peri-implant dehiscence defect area.
In the PCL/PLGA/β-TCP group (figure 15), a com-
paratively large amount of new bone was formed in the 
implant in the buccal peri-implant dehiscence defect 
area. The membranes survived in most of the speci-
mens, and a large amount of the grafting material that 
formed a shape was observed in the peri-implant dehis-
cence defect area.
Table 2. Volumetric analysis within the area of interest (n  =  6; mm3).
NBV (mm3) TAV (mm3) RBV (mm3) NMV (mm3)
Collagen
 Mean  ±  SD 1.28  ±  0.70 14.27  ±  0.19 2.69  ±  1.97 10.29  ±  2.71
 Median 0.98 14.27 1.88 11.42
PCL/PLGA/β-TCP
 Mean  ±  SD 1.57  ±  0.70 14.04  ±  0.31 3.95  ±  1.97 8.52  ±  2.47
 Median 1.56 14.05 4.15 8.23
 P 0.339 0.127 0.295 0.185
Note: NBV, new bone volume; TAV, total augmented volume; RBV, remaining bone 
substitute volume; NMV, non-mineralized tissue volume.
No significant difference between the two experiment groups (P  >  0.05).
Figure 13. Scatter plot and median (plus sign) representing the new bone volume (mm3).
Figure 14. Histological sections of the collagen group. A small amount of new bone was formed. NB, new bone; GM, grafting 
material; MEM, membrane; I, implant (Goldner Trichrome stain; magnification  ×12.5 (a) and  ×40 (b)).
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3.4.4. Histometric analysis 
The histometric measurements are summarized in 
table 3 and figure 16. The PCL/PLGA/β-TCP group 
showed significantly higher levels than the collagen 
group. In terms of the new bone area and the bone- 
to-implant contact; (NBA (%), P  =  0.000; and BIC 
(%), P  =  0.000). The PCL/PLGA/β-TCP group also 
showed higher levels of the collagen group in terms of 
the remaining bone substitute area (%), BC-OB (%) 
and CO-OB (%), but the difference was insignificant 
(RBA (%), P  =  0.256; BC-OB (%), P  =  0.759; and 
CO-OB (%), P  =  0.185).
4. Discussion
GBR maintains the defect area after the extraction of 
a tooth before an implant, enhancing the migration 
of surrounding bone tissue and preventing ingrowth 
of soft tissue [42]. GBR is removed approximately 3–4 
months after surgery when the bone is reconstructed 
and ready for an implant. For these reasons, first, GBR 
membranes must be biocompatible to allow migration 
and proliferation of the surrounding tissue. In 
addition, GBR membranes must be able to protect the 
wound area from mechanical disruption and salivary 
contamination and must be naturally resorbed so that 
an additional surgery is not required for their removal 
[43–45]. Collagen membranes have gained popularity 
as a GBR membrane as they facilitate cell attachment 
and proliferation in the defect area, resulting in 
effective bone formation, are bioresorbable within 4 
weeks after the application, which obviates a second 
surgery for removal, and have little immunogenicity 
[18, 22, 46, 47]. Hence, for comparison with collagen 
membranes, this study fabricated 3D-printed PCL/
PLGA/β-TCP membranes using a combination of 
TCP, a biodegradable material known to induce bone 
formation by releasing calcium, and two biocompatible 
polymers, PCL and PLGA [37, 38].
Synthetic biomaterials such as PCL, poly lactic acid, 
poly glycolic acid, and PLGA have been used to prepare 
the scaffolds for enhanced tissue regeneration [36]. In 
particular, PLGA is used for the reconstruction of vari-
ous tissues owing to its high cytocompatibility [36, 48, 
49].
However, scaffolds composed only of PLGA do not 
maintain their shapes either in the in vitro or in vivo 
environments owing to their brittle property and rapid 
Figure 15. Histological sections of the PCL/PLGA/β-TCP group. A large amount of new bone was formed. NB, new bone; GM, 
grafting material; MEM, membrane; I, implant (Goldner Trichrome stain; magnification  ×12.5 (a) and  ×40 (b)).
Table 3. Histometric analysis within the area of interest (n  =  6; %).
NBA (%) RBA (%) BIC (%) BC-OB (%) CO-OB (%)
Collagen
 Mean  ±  SD 13.84  ±  4.60 16.08  ±  3.25 40.22  ±  10.71 55.81  ±  9.41 47.03  ±  10.19
 Median 12.86 15.69 38.00 52.70 46.15
PCL/PLGA/β-TCP
 Mean  ±  SD 24.36  ±  3.90 19.19  ±  5.28 56.48  ±  4.68 57.11  ±  6.08 51.59  ±  8.51
 Median 24.07 18.37 57.63 58.69 52.62
 P 0.000a 0.256 0.000a 0.759 0.185
aIndicates statistical significance between the two experiment groups (P  <  0.05).
Note: NBA, new bone area; RBA, remaining bone substitute area; BIC, bone-to-implant contact;  
BC-OB, distance from the bone crest to the old bone; CO-OB, distance from the most coronal point  
of the osseointegration to the old bone.
Biomed. Mater. 11 (2016) 055013
13
J-Y Won et al
resorption [34, 50]. In contrast, PCL has comparatively 
less cell affinity than PLGA, but it has excellent mechan-
ical properties that prevent early fractures of the scaf-
fold [39] and its degradation rate is slower than the rate 
of bone regeneration [51]. Thus, blended PCL/PLGA 
scaffolds exhibit biological and mechanical advantages 
obtained during the PCL and PLGA mixing processes 
that complement their respective weaknesses [36]. In 
addition, as β-TCP was added to the blended PCL/
PLGA for the fabrication of the PCL/PLGA/β-TCP 
membrane, their elastic modulus was enhanced and 
their surface roughness was increased [1, 52, 53]. In the 
SEM images of the PCL/PLGA/β-TCP membranes pre-
pared in this study, the rough surfaces generated by the 
incorporated β-TCP were confirmed (figure 7). During 
cellular testing with fibroblasts and preosteoblasts, early 
cell attachment and differentiation were higher in colla-
gen, but the difference of proliferation and differentia-
tion had disappeared when examined on day 7 and day 
14, respectively. In contrast, fibroblasts aggregated and 
were detached from the membrane when maintained 
until day 14 (data not shown). This was in line with the 
results of a previous paper [40] and is an indication of 
the membrane’s ability to inhibit the ingrowth of soft 
tissues.
We next applied the GBR to an in vivo implant 
model utilizing beagle dogs and performed histologi-
cal analyses after sacrifice at 8 weeks. The histologic and 
histomorphometric analyses in this study showed that 
the PCL/PLGA/β-TCP group did not differ significantly 
from the collagen group; furthermore, in particular 
among the histometric measurements, the new bone 
area (%) and bone-to implant contact (%) of the PCL/
PLGA/β-TCP group were significantly higher than 
those of the collagen group (P  <  0.05). These findings 
indicated that the group receiving PCL/PLGA/β-TCP 
membranes showed levels of new bone formation and 
regeneration in the defect area comparable with those 
induced by collagen membranes, confirming that the 
biocompatibility of the PCL/PLGA/β-TCP membranes 
as well as their ability to maintain migration and prolif-
eration of surrounding tissue and to support osteogenic 
differentiation to ultimately induce bone formation are 
comparable to those of collagen.
Rakhmatia et al [9] suggested that a non-resorba-
ble titanium mesh could be an excellent solution when 
special mechanical support is required for bone defect 
treatments. According to Hämmerle & Jung [13], a 
titanium-reinforced e-PTFE membrane can be used 
in GBR for large defects; on the other hand, in casual 
dehiscence defect cases, the resorbable membrane is the 
current material of choice. However, in response to a 
report that resorbable membranes such as collagen have 
disadvantages as barriers owing to inferior generation 
of implant space caused by their poor mechanical prop-
erties [12], we performed mechanical property testing 
Figure 16. Scatter plot and median (plus sign) representing (a) the new bone area, (b) bone-to-implant contact within the defect, 
(c) distance from the bone crest to the old bone, and (d) distance from the most coronal point of the osseointegration to the old bone 
(n  =  6). *Significantly different (P  <  0.05).
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for PCL/PLGA/β-TCP membranes under biomimetic 
dry and wet conditions. As shown in figures 8 and 9, 
and table 1, the elastic modulus of collagen markedly 
decreased in dry and wet conditions whereas that of the 
PCL/PLGA/β-TCP membrane was relatively stable. 
Furthermore, in the volumetric analysis using µCT, the 
PCL/PLGA/β-TCP group showed a greater new bone 
volume (mm3) than the collagen group. This might 
have been due to the stability of the PCL/PLGA/β-TCP 
membrane based on its superior mechanical properties 
and slower degradation rate. This finding shows that 
PCL/PLGA/β-TCP membranes are stable in main-
taining their structure and during the space-making 
required for bone regeneration in defect areas exposed 
to blood, saliva, and irrigation, which would be a ben-
eficial property for use as a GBR membrane.
In addition, the PCL/PLGA/β-TCP membrane can 
be prepared quickly and economically using 3D print-
ing technology to generate diverse shapes, thicknesses, 
pore sizes, pore geometries, and porosities. Upon load-
ing antibiotics, growth factors, or adhesion factors, this 
synthetic membrane can be used as a delivery device 
for specific agents [38, 54]. In addition, its mechani-
cal properties and degradation rate can be modified 
according to the component ratio. Actually, in the previ-
ously study, we combined PCL/PLGA/β-TCP in a ratio 
of 2:6:2, to manufacture a membrane that would reflect 
the stiff properties of PLGA with the focusing physical 
strength like titanium membrane [39, 40]. In the pre-
sent experiment, PCL/PLGA/β-TCP was combined in 
a ratio of 4:5:1. Increasing the proportion of PCL aims 
to make the membrane flexible, like a collagen mem-
brane, while also acquiring a little space maintaining 
ability. Therefore, the membranes used in this study 
were much softer than those used in the previous study 
[40], and we could bended and shaped membranes 
to fit the patient’s defect, ultimately maintaining the 
space for bone regeneration. It will be also helpful to 
maintain the bone grafting materials within defect area. 
We concluded from this study that this membrane is 
more effective in handling and maintaining the space 
while it also embraces the advantages of collagen mem-
brane such as resorption, biocompatibility and barrier 
function.
Overall, our results demonstrate that the 
3D-printed PCL/PLGA/β-TCP membrane is useful as 
a GBR membrane. In addition, it can be prepared in the 
form of a patient-specific membrane from personal CT 
scan data, and it can be fabricated as a drug- or growth 
factor-releasing bioactive membrane. Further studies 
will likely be required to define and optimize these and 
other potential future uses.
5. Conclusions
In this study, the 3D-printed PCL/PLGA/β-TCP 
membrane showed a bone regeneration performance 
similar to that of collagen membranes during a 
GBR procedure performed in peri-implant defects. 
Therefore, the 3D-printed PCL/PLGA/β-TCP 
membrane was confirmed to have substantial efficacy 
as a resorbable GBR membrane for peri-implant 
defect treatment. Considering the higher stability 
of membrane, the 3D-printed PCL/PLGA/β-TCP 
membrane is expected to become a feasible alternative 
to the commonly utilized collagen membrane.
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